Mallinckrodt Announces Plans to Update Its Incentive Compensation Clawback Policy and Create Opioid Report

STAINES-UPON-THAMES, United Kingdom, Dec. 10, 2019 /PRNewswire/ — Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced plans to update Mallinckrodt’s Incentive Compensation Clawback Policy and to develop and publish a report on the Board’s oversight of risks…

About the Author

has written 42175 stories on this site.

Copyright © 2010 Business and Corporate News.